These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27453425)

  • 61. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts.
    Liemburg E; Castelein S; Stewart R; van der Gaag M; Aleman A; Knegtering H;
    J Psychiatr Res; 2013 Jun; 47(6):718-25. PubMed ID: 23472837
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Negative symptoms in schizophrenia: avolition and Occam's razor.
    Foussias G; Remington G
    Schizophr Bull; 2010 Mar; 36(2):359-69. PubMed ID: 18644851
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders.
    Lyngstad SH; Lyne JP; Ihler HM; van der Meer L; Færden A; Melle I
    Schizophr Bull; 2023 Sep; 49(5):1099-1104. PubMed ID: 37193675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apathy syndrome after traumatic brain injury compared with deficits in schizophrenia.
    Rao V; Spiro JR; Schretlen DJ; Cascella NG
    Psychosomatics; 2007; 48(3):217-22. PubMed ID: 17478590
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The negative syndrome of schizophrenia: three -underlying components are better than two.
    Garcia-Portilla MP; Garcia-Alvarez L; Mané A; Garcia-Rizo C; Sugranyes G; Bergé D; Bernardo M; Fernández-Egea E; Bobes J
    Schizophr Res; 2015 Aug; 166(1-3):115-8. PubMed ID: 26044112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
    Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Secondary negative symptoms - A review of mechanisms, assessment and treatment.
    Kirschner M; Aleman A; Kaiser S
    Schizophr Res; 2017 Aug; 186():29-38. PubMed ID: 27230288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discrepancies between ideal and actual affect in schizophrenia: Implications for understanding negative symptoms.
    James SH; Berglund A; Chang WC; Strauss GP
    J Psychiatr Res; 2022 Nov; 155():313-319. PubMed ID: 36174366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The current conceptualization of negative symptoms in schizophrenia.
    Marder SR; Galderisi S
    World Psychiatry; 2017 Feb; 16(1):14-24. PubMed ID: 28127915
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model.
    Sahin C; Doostdar N; Neill JC
    Behav Brain Res; 2016 Oct; 312():93-101. PubMed ID: 27312268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Baseline social amotivation predicts 1-year functioning in UHR subjects: A validation and prospective investigation.
    Lam M; Abdul Rashid NA; Lee SA; Lim J; Foussias G; Fervaha G; Ruhrman S; Remington G; Lee J
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2187-96. PubMed ID: 26553972
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.
    Winograd-Gurvich C; Fitzgerald PB; Georgiou-Karistianis N; Bradshaw JL; White OB
    Brain Res Bull; 2006 Oct; 70(4-6):312-21. PubMed ID: 17027767
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An investigation into the drivers of avolition in schizophrenia.
    Suri G; Lavaysse LM; Young G; Moodie C; Tersakyan A; Gross JJ; Gard DE
    Psychiatry Res; 2018 Mar; 261():225-231. PubMed ID: 29329039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lexical Diversity and Other Linguistic Measures in Schizophrenia: Associations With Negative Symptoms and Neurocognitive Performance.
    Compton MT; Ku BS; Covington MA; Metzger C; Hogoboom A
    J Nerv Ment Dis; 2023 Aug; 211(8):613-620. PubMed ID: 37256631
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophrenia.
    Kluge A; Kirschner M; Hager OM; Bischof M; Habermeyer B; Seifritz E; Walther S; Kaiser S
    Schizophr Res; 2018 May; 195():176-182. PubMed ID: 29030262
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Schizophrenia: measurements of psychopathology.
    Lindenmayer JP; Harvey PD; Khan A; Kirkpatrick B
    Psychiatr Clin North Am; 2007 Sep; 30(3):339-63. PubMed ID: 17720027
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apathy in schizophrenia: clinical correlates and association with functional outcome.
    Kiang M; Christensen BK; Remington G; Kapur S
    Schizophr Res; 2003 Sep; 63(1-2):79-88. PubMed ID: 12892861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.